We conclude that CTSB expression may be useful for determining OSCC prognosis, particularly for patients with lymph node metastasis, and may function as a biomarker of the survival of OSCC patients in Taiwan. Here, CTSB is linked to metastatic malignant neoplasm in the lymph nodes.